CHELMSFORD, Mass. and CLEVELAND, May 21,
2018 /PRNewswire/ -- Cleveland Clinic and Brooks
Automation. Inc. (Nasdaq: BRKS) will launch a 21,000-square-foot
biorepository in Cleveland's
Fairfax neighborhood to enhance
researchers' study of human tissue samples and advance personalized
medicine for an array of conditions – including cancer, heart
disease, and epilepsy.
This state-of-the-art facility will increase Cleveland Clinic's
existing biobanking capacity and accelerate translational research
through streamlined patient consent processes and centralized
storage.
"This new biorepository will be a critical resource for our
scientists. Biobanking is essential for the evolution of
personalized medicine. The ability to properly manage biological
specimens and to compare diseased tissues side-by-side with healthy
tissues, is essential to understanding the biological basis of a
disease," said Serpil Erzurum, MD,
chair of Cleveland Clinic Lerner Research Institute. "As a leading
healthcare organization, this provides an unparalleled opportunity
to advance understanding of many different
diseases, enabling us to make
discoveries that are directly benefitting our patients."
The two-story building will be located on the Cleveland Clinic's
campus and is expected to be completed in summer 2019. Brooks Life
Sciences, a division of Brooks Automation and a global leader in
sample management solutions, will manage the onsite operations to
include storing and maintaining high-value collections of
biological material safely and efficiently. They will begin with
the launch of a sample inventory process that will annotate each
sample within the storage facility before moving material to the
new biorepository.
"With an international reputation as a leader in medical
research, Cleveland Clinic understands the value sample management
plays in medical research and is committed to improving patient
outcomes," said Brooks Life Sciences President Dusty Tenney. "We are extremely proud to be
partnering with Cleveland Clinic to manage the operations of its
new biobank and to offer our expertise in sample management."
About Brooks Automation, Inc.
Brooks is a
leading worldwide provider of automation and cryogenic solutions
for multiple markets including semiconductor manufacturing and life
sciences. Brooks' technologies, engineering competencies and global
service capabilities provide customers speed to market and ensure
high uptime and rapid response, which equate to superior value in
their mission-critical controlled environments. Since 1978,
Brooks has been a leading partner to the global semiconductor
manufacturing market. Since 2011, Brooks has applied its
automation and cryogenics expertise to meet the sample storage
needs of customers in the life sciences industry. Brooks Life
Sciences, a division of Brooks Automation, provides a broad range
of products and services for on-site infrastructure for sample
management in temperatures of ‑20°C to -150°C, as well as
comprehensive outsource service solutions across the complete life
cycle of biological samples including collection, transportation,
processing, storage, protection, retrieval and disposal that
accelerate research and improve patient health. Brooks is
headquartered in Chelmsford, MA,
with direct operations in North
America, Europe and
Asia. For more information, visit
www.brooks.com.
About Cleveland Clinic
Cleveland Clinic is a
nonprofit multispecialty academic medical center that integrates
clinical and hospital care with research and education. Located in
Cleveland, Ohio, it was founded in
1921 by four renowned physicians with a vision of providing
outstanding patient care based upon the principles of cooperation,
compassion and innovation. Cleveland Clinic has pioneered many
medical breakthroughs, including coronary artery bypass surgery and
the first face transplant in the United
States. U.S. News & World Report consistently names
Cleveland Clinic as one of the nation's best hospitals in its
annual "America's Best Hospitals" survey. Among Cleveland Clinic's
52,000 employees are more than 3,600 full-time salaried physicians
and researchers and 14,000 nurses, representing 140 medical
specialties and subspecialties. Cleveland Clinic's health system
includes a 165-acre main campus near downtown Cleveland, 11 regional hospitals, more than
150 northern Ohio outpatient
locations – including 18 full-service family health centers and
three health and wellness centers – and locations in Weston, Fla.; Las
Vegas, Nev.; Toronto,
Canada; Abu Dhabi, UAE; and
London, England. In 2017, there
were 7.6 million outpatient visits, 229,000 hospital admissions and
207,000 surgical cases throughout Cleveland Clinic's health system.
Patients came for treatment from every state and 185 countries.
Visit us at clevelandclinic.org. Follow us at
twitter.com/ClevelandClinic. News and resources are available at
newsroom.clevelandclinic.org.
"Safe Harbor Statement" under Section 21E of the Securities
Exchange Act of 1934
Some statements in this release are forward-looking statements
made under Section 21E of the Securities Exchange Act of 1934.
These statements are neither promises nor guarantees but involve
risks and uncertainties, both known and unknown, that could cause
Brooks' financial and business results to differ materially from
our expectations. They are based on the facts known to management
at the time they are made. These forward-looking statements
include, but are not limited to, statements about the expected
timing for completion of the biorepository and the anticipated
benefits of working with Cleveland Clinic. In addition,
actual results are subject to other risks that relate more broadly
to Brooks' overall business, including those that we have described
in our filings with the Securities and Exchange Commission,
including but not limited to our Annual Report on Form 10-K,
current reports on Form 8-K and our quarterly reports on Form 10-Q.
As a result we can provide no assurance that our future results
will not be materially different from those projected. Brooks
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any such statement to reflect
any change in our expectations or any change in events, conditions
or circumstances on which any such statement is based. Brooks
undertakes no obligation to update the information contained in
this press release.
Media contact information:
Brooks Life Sciences
Marla Kertzman
Phone +1 (209) 852-9027
marla@thoroughbred-communications.com
Investor Contacts:
Sherry Dinsmore
Brooks Automation
978.262.4301
sherry.dinsmore@brooks.com
John Mills
Managing Partner
ICR, LLC
646.277.1254
john.mills@icrinc.com
View original
content:http://www.prnewswire.com/news-releases/cleveland-clinic-and-brooks-automation-announce-new-biobanking-facility-300651148.html
SOURCE Brooks Automation